143491-57-0
Chemical Structure
Emtricitabine
Synonym(s): BW1592
- CAS No.: 143491-57-0
- Formula:C8H10FN3O3S
- Molecular Weight:247.25
IUPAC Name: 4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
InChIKey: XQSPYNMVSIKCOC-NTSWFWBYSA-N
SMILES: O=C1N=C(N)C(F)=CN1[C@@H]2CS[C@H](CO)O2
Biological Activity: Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 value of 0.01 μM in PBMC cells. Emtricitabine inhibits HIV reverse transcriptase, preventing RNA from being transcribed into DNA. Emtricitabine has low brain permeability (logP <0)[1][2][3][4][5].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Emtricitabine | 99.97% | Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 value of 0.01 μM in PBMC cells. Emtricitabine inhibits HIV reverse transcriptase, preventing RNA from being transcribed into DNA. Emtricitabine has low brain permeability (logP <0). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine (Standard) | 99.98% | Emtricitabine (Standard) is the analytical standard of Emtricitabine. This product is intended for research and analytical applications. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine-15N,d2 | 97.64% | Emtricitabine-15N,d2 is a 15N-labeled and deuterium labeled Emtricitabine. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine-13C,15N2 | Emtricitabine-13C,15N2 (BW1592-13C,15N2) is a 13C- and 15N-labeled Emtricitabine (HY-17427). Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine-d2 | Emtricitabine-d2 (BW1592-d2) is deuterium labeled Emtricitabine. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||